Norway· NO-ID_C528CEA5-8C9A-408B-A165-C23F8CEF2A34

Keveyis

A diclofenamide product containing diklofenamid, registered in Norway by Taro Pharmaceutical Industries, Ltd.. The same ATC class is registered in 3 of our 19 countries.

ATC S01EC02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedKeveyisATCS01EC02REGISTER NO.NO-ID_C528CEA5-8C9A-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Diclofenamide is registered in 3 of 19 countries.

Countries holding a registration under ATC S01EC02 (diclofenamide), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 2 of them publish a price we can compare per daily dose

Diclofenamide · ATC S01EC02

3 / 19 countries

  • Finlandprice
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Diklofenamid
Manufacturer
Taro Pharmaceutical Industries, Ltd.
Country
Norway (NO)
ATC code
S01EC02
ATC class
Diclofenamide
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_varenummer
    259669
    100
  • gtin
    372065001019
  • no_merkevare_id
    ID_C528CEA5-8C9A-408B-A165-C23F8CEF2A34

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

138 interactions on record for diclofenamide.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diclofenamide · interactions on record

138 records

  • 7 severe
  • 126 moderate
  • 5 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • MetforminA10BA02severe
  • Acetylsalicylic acidB01AC06severe
  • Salicylic acidD01AE12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diclofenamide in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenamide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1eef152f-0ba4-473e-8514-4ebdea098ba5
GET /v1/drugs/1eef152f-0ba4-473e-8514-4ebdea098ba5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Diklofenamid",
  "merkevare_id": "ID_C528CEA5-8C9A-408B-A165-C23F8CEF2A34",
  "name_form_strength": "Keveyis tab 50 mg",
  "prescription_group": "C"
}

See everything about diclofenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.